AIM:To present the clinical outcomes in efficacy and safety of the Ahmed ClearPath®(ACP)250 mm2 model as well as our surgical technique.METHODS:Single-center prospective interventional study of uncontrolled glauc...AIM:To present the clinical outcomes in efficacy and safety of the Ahmed ClearPath®(ACP)250 mm2 model as well as our surgical technique.METHODS:Single-center prospective interventional study of uncontrolled glaucoma eyes undergoing ACP implantation,as a standalone procedure or in combination with cataract phacoemulsification.Intraocular pressure(IOP)was evaluated prior to surgery and 1wk,1,3,6mo and 1y postoperatively.In addition,the number of antiglaucoma drugs and intra and postoperative complications were assessed.RESULTS:A total of 30 eyes of 28 patients were included in the study.The patients were on average 72.8(13.4)years old and 53.6%were male.Totally 40%of the eyes had primary open angle glaucoma,16.7%had neovascular glaucoma,16.7%had pseudoexfoliative glaucoma,10%had glaucoma secondary to pars plana vitrectomy with silicone oil tamponade,6.7%had aphakic glaucoma,6.7%had primary congenital glaucoma and 3.3%had pigmentary glaucoma.Before surgery mean IOP was 26.1(10.8)mm Hg and mean glaucoma medication use was 3.7(0.5).At 1,3,6 and 12mo mean IOP was 16.1,11.7,11.8 and 11.5 mm Hg,respectively.Mean glaucoma medication use was 1.9,1.5,1.2 and 1.2,respectively.At 1y,complete surgical success was found in 46.7%patients(n=14)and qualified success in 53.3%(n=16).There were no intraoperative complications.Postoperative complications include choroidal effusion(n=5),transient hyphema(n=2),early hypotony with shallow anterior chamber(n=2)and late hemorrhagic choroidal detachment(n=1).CONCLUSION:The ACP appears to be an efficient surgical option for treating refractory glaucoma,achieving good IOP control and decreasing medication burden.The results obtained at 6mo are an important prognostic factor for long-term outcomes.展开更多
12月9日,适马正式发布新款电影镜头AF CINE 28-45mm T2。该镜头将自动对焦技术与电影镜头标准深度融合,旨在为影视创作者在复杂多变的拍摄环境中提供强大而灵活的创作支持。AF CINE 28-45mm T2融合了适马多年的镜头设计经验、最新研发...12月9日,适马正式发布新款电影镜头AF CINE 28-45mm T2。该镜头将自动对焦技术与电影镜头标准深度融合,旨在为影视创作者在复杂多变的拍摄环境中提供强大而灵活的创作支持。AF CINE 28-45mm T2融合了适马多年的镜头设计经验、最新研发技术以及先进的制作工艺。该镜头在任何焦距与对焦距离下均能提供出色的解析度和唯美的焦外虚化,同时有效抑制眩光与鬼影,确保画面锐利、纯净。该镜头搭载了HLA(高速线性马达),无论是动作场面中的剧烈运动、使用稳定器或手持拍摄时的快速焦点切换,还是纪录片中不可预知的瞬间,都能分秒不差地精准捕捉,为影视创作者在各种拍摄环境下提供可靠支持。展开更多
文摘AIM:To present the clinical outcomes in efficacy and safety of the Ahmed ClearPath®(ACP)250 mm2 model as well as our surgical technique.METHODS:Single-center prospective interventional study of uncontrolled glaucoma eyes undergoing ACP implantation,as a standalone procedure or in combination with cataract phacoemulsification.Intraocular pressure(IOP)was evaluated prior to surgery and 1wk,1,3,6mo and 1y postoperatively.In addition,the number of antiglaucoma drugs and intra and postoperative complications were assessed.RESULTS:A total of 30 eyes of 28 patients were included in the study.The patients were on average 72.8(13.4)years old and 53.6%were male.Totally 40%of the eyes had primary open angle glaucoma,16.7%had neovascular glaucoma,16.7%had pseudoexfoliative glaucoma,10%had glaucoma secondary to pars plana vitrectomy with silicone oil tamponade,6.7%had aphakic glaucoma,6.7%had primary congenital glaucoma and 3.3%had pigmentary glaucoma.Before surgery mean IOP was 26.1(10.8)mm Hg and mean glaucoma medication use was 3.7(0.5).At 1,3,6 and 12mo mean IOP was 16.1,11.7,11.8 and 11.5 mm Hg,respectively.Mean glaucoma medication use was 1.9,1.5,1.2 and 1.2,respectively.At 1y,complete surgical success was found in 46.7%patients(n=14)and qualified success in 53.3%(n=16).There were no intraoperative complications.Postoperative complications include choroidal effusion(n=5),transient hyphema(n=2),early hypotony with shallow anterior chamber(n=2)and late hemorrhagic choroidal detachment(n=1).CONCLUSION:The ACP appears to be an efficient surgical option for treating refractory glaucoma,achieving good IOP control and decreasing medication burden.The results obtained at 6mo are an important prognostic factor for long-term outcomes.
文摘12月9日,适马正式发布新款电影镜头AF CINE 28-45mm T2。该镜头将自动对焦技术与电影镜头标准深度融合,旨在为影视创作者在复杂多变的拍摄环境中提供强大而灵活的创作支持。AF CINE 28-45mm T2融合了适马多年的镜头设计经验、最新研发技术以及先进的制作工艺。该镜头在任何焦距与对焦距离下均能提供出色的解析度和唯美的焦外虚化,同时有效抑制眩光与鬼影,确保画面锐利、纯净。该镜头搭载了HLA(高速线性马达),无论是动作场面中的剧烈运动、使用稳定器或手持拍摄时的快速焦点切换,还是纪录片中不可预知的瞬间,都能分秒不差地精准捕捉,为影视创作者在各种拍摄环境下提供可靠支持。
